TY  - CONF 
AU  - Mel Lorenzo, José Ramón
PY  - 2011
SN  - 1465-5411
UR  - http://hdl.handle.net/20.500.11940/6851
LA  - eng
TI  - Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.
DO  - http://dx.doi.org/10.1186/bcr302...
VL  - 13
ER  -